VALLOUREC SA (VK.PA)

FR0013506730 - Common Stock

10.16  +0.07 (+0.74%)


Fundamental Rating

2

Taking everything into account, VK scores 2 out of 10 in our fundamental rating. VK was compared to 31 industry peers in the Energy Equipment & Services industry. Both the profitability and financial health of VK have multiple concerns. VK has a correct valuation and a medium growth rate.

Note: VK has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

0


VS Industry

Valuation

Valuation Rating

5

The Forward Price/Earnings Ratio of 3.64 indicates a rather cheap valuation of VK.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the Enterprise Value to EBITDA ratio of VK to the average industry ratio of 4.24, VK is valued rather cheaply.

When comparing the current price to the book value of VK, we can conclude it is valued correctly. It is trading at 1.28 times its book value.
Compared to an average industry price book ratio of 1.32, VK is valued in line with its industry peers.
VK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
VS Industry

Price/Book (1.28) VS Industry: 53% outperformed.

33.16
0.41

Enterprise Value/ EBITDA (2.19) VS Industry: 78% outperformed.

31.17
0.40

Growth

Growth Rating

4

The Earnings Per Share is expected to grow by 33.43% on average over the next 5 years. This is a very strong growth
The Revenue has grown by 44.51% in the past year. This is a very strong growth!
Measured over the past 5 years, VK shows a small growth in Revenue. The Revenue has been growing by 5.42% on average per year.

Based on estimates for the next 5 years, VK will show a decrease in Revenue. The Revenue will decrease by -3.51% on average per year.
The earnings per share for VK have decreased strongly by -9064.65% in the last year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -9064.65% 248.17% 92.65% 56.78% 33.43%
Revenue5.42% 5.37% 44.51% 8.51% 6.36% 3.16% -3.51%

Health

Health Rating

1

A Current Ratio of 1.67 indicates that VK should not have too much problems paying its short term obligations.
The Current Ratio is in line with the industry averages, which is at 1.67.
A Quick Ratio of 0.99 indicates that VK may have some problems paying its short term obligations.

When comparing the Quick Ratio of VK to the average industry Current Ratio of 1.33, VK is less able to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.42, VK is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (0.78) VS Industry: 38% outperformed.

62.02
0.00

Quick Ratio (0.99) VS Industry: 29% outperformed.

0.32
23.83

Current Ratio (1.67) VS Industry: 51% outperformed.

0.32
23.83

Dividend

Dividend Rating

0

VK does not give a dividend.

VALLOUREC SA

EPA:VK (5/29/2023, 7:00:00 PM)

10.16

+0.07 (+0.74%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.33B
Analysts85.33
Price Target20.5 (101.77%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)-48.42%
Min EPS beat(2)-48.42%
Max EPS beat(2)-48.42%
EPS beat(4)N/A
Avg EPS beat(4)-159.4%
Min EPS beat(4)-336.89%
Max EPS beat(4)-48.42%
Revenue beat(2)1
Avg Revenue beat(2)79.2%
Min Revenue beat(2)79.2%
Max Revenue beat(2)79.2%
Revenue beat(4)2
Avg Revenue beat(4)48.46%
Min Revenue beat(4)-7.84%
Max Revenue beat(4)79.2%
PT rev (1m)0%
PT rev (3m)6.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.92%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.64
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 1.28
P/tB 1.35
EV/EBITDA 2.19
EPS(TTM)-1.63
EYN/A
EPS(NY)2.79
Fwd EY27.46%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.77
BVpS7.92
TBVpS7.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 17.56%
ROICexc 23.04%
ROICexgc 23.78%
OM 11.97%
PM N/A
GM 23.53%
ROICexgc(3y)N/A
ROICexcg growth 3Y102.09%
ROICexcg growth 5YN/A
ROICexc(3y)N/A
ROICexc growth 3Y114.21%
ROICexc growth 5YN/A
OM growth 3Y119.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.61%
GM growth 5Y12.79%
F-ScoreN/A
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 1.27
Cap/Depr N/A
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 0.99
Altman-Z N/A
F-ScoreN/A
WACC8.42%
ROIC/WACC2.82
Cap/Depr(3y)45.62%
Cap/Depr(5y)47.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-9064.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q537.88%
EPS Next Y248.17%
EPS Next 2Y92.65%
EPS Next 3Y56.78%
EPS Next 5Y33.43%
Revenue growth 1Y44.51%
Revenue growth 3Y5.37%
Revenue growth 5Y5.42%
Revenue growth Q2Q46.07%
Revenue Next Year8.51%
Revenue Next 2Y6.36%
Revenue Next 3Y3.16%
Revenue Next 5Y-3.51%
EBIT growth 1Y149.55%
EBIT growth 3Y131.71%
EBIT growth 5YN/A
EBIT Next Year254.3%
EBIT Next 3Y56.35%
EBIT Next 5Y16.71%
FCF growth 1Y22.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.08%
OCF growth 3YN/A
OCF growth 5YN/A
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext